List view / Grid view

Dr Pablo Menéndez (Senior Group Leader the Josep Carreras Leukaemia Research Institute)

 

news

Dual CAR-T cell therapy targets T-ALL with precision

A new dual CAR-T cell therapy targeting two tumour-specific proteins…

16 July 2025 | By

A new dual CAR-T cell therapy targeting two tumour-specific proteins in T-cell Acute Lymphoblastic Leukaemia (T-ALL) has been developed – meaning effective treatment for this aggressive blood cancer could soon become a reality.